ORPHAN

Pharmaceuticals for the treatment of rare diseases, namely, in the field of cardiology, diseases affecting immunocompromised patients, genetic disorders, haematology, infectious diseases, metabolic disorders, oncology, pallative care, poison control, respiratory diseases, urology and psychiatric diseases

product research and development of prescription and over-the-counter drugs